These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 17342021)

  • 1. Ziana (clindamycin phosphate 1.2% and tretinoin 0.025%)gel.
    Gupta AK; Gover MD; Abramovits W
    Skinmed; 2007; 6(2):85-7. PubMed ID: 17342021
    [No Abstract]   [Full Text] [Related]  

  • 2. Clindamycin phosphate plus tretinoin 1.2%/0.025% gel (Ziana) for acne.
    Skinmed; 2007; 6(3):135-6. PubMed ID: 17478992
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical efficacy of Velac, a new tretinoin and clindamycin phosphate gel in acne vulgaris.
    Cambazard F
    J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S20-7; discussion S28-9. PubMed ID: 9891905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clindamycin phosphate 1.2% / tretinoin 0.025%: a novel fixed-dose combination treatment for acne vulgaris.
    Ochsendorf F
    J Eur Acad Dermatol Venereol; 2015 Jun; 29 Suppl 5():8-13. PubMed ID: 26059820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel gel formulation of 0.25% tretinoin and 1.2% clindamycin phosphate: efficacy in acne vulgaris patients aged 12 to 18 years.
    Eichenfield LF; Wortzman M
    Pediatr Dermatol; 2009; 26(3):257-61. PubMed ID: 19706084
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
    Draelos ZD; Potts A; Alió Saenz AB;
    Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Veltin gel (clindamycin phosphate 1.2% and tretinoin 0.025%).
    Abramovits W; Oquendo M; Gupta AK
    Skinmed; 2011; 9(1):49-51. PubMed ID: 21409962
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of clindamycin/benzoyl peroxide, tretinoin plus clindamycin, and the combination of clindamycin/benzoyl peroxide and tretinoin plus clindamycin in the treatment of acne vulgaris: a randomized, blinded study.
    Bowman S; Gold M; Nasir A; Vamvakias G
    J Drugs Dermatol; 2005; 4(5):611-8. PubMed ID: 16167420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and safety of clindamycin-tretinoin gel versus clindamycin or tretinoin alone in acne vulgaris: a randomized, double-blind, vehicle-controlled study.
    Jarratt MT; Brundage T
    J Drugs Dermatol; 2012 Mar; 11(3):318-26. PubMed ID: 22395582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combining clindamycin 1%-benzoyl peroxide 5% gel with multiple therapeutic options.
    Bikowski J; Callender VD; Del Rosso JQ; Draelos ZD; Tanghetti E
    Cutis; 2006 Aug; 78(2 Suppl 1):13-20. PubMed ID: 17966495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and tolerability of clindamycin phosphate and salicylic acid gel in the treatment of mild to moderate acne vulgaris.
    Touitou E; Godin B; Shumilov M; Bishouty N; Ainbinder D; Shouval R; Ingber A; Leibovici V
    J Eur Acad Dermatol Venereol; 2008 May; 22(5):629-31. PubMed ID: 18410627
    [No Abstract]   [Full Text] [Related]  

  • 13. Clindamycin phosphate 1.2%- tretinoin 0.025% gel: vehicle characteristics, stability, and tolerability.
    Del Rosso JQ; Jitpraphai W; Bhambri S; Momin S
    Cutis; 2008 May; 81(5):405-8. PubMed ID: 18543590
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of acne vulgaris: combination of 3% erythromycin and 5% benzoyl peroxide in a gel compared to clindamycin phosphate lotion.
    Packman AM; Brown RH; Dunlap FE; Kraus SJ; Webster GF
    Int J Dermatol; 1996 Mar; 35(3):209-11. PubMed ID: 8655242
    [No Abstract]   [Full Text] [Related]  

  • 15. Clindamycin phosphate-tretinoin combination gel revisited: status report on a specific formulation used for acne treatment.
    Del Rosso JQ
    Cutis; 2017 Mar; 99(3):179-183. PubMed ID: 28398420
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advances in topical delivery systems in acne: new solutions to address concentration dependent irritation and dryness.
    Ceilley RI
    Skinmed; 2011; 9(1):15-21. PubMed ID: 21409958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treating acne: avoid the development of antibiotic resistance by applying topical and combined therapy].
    Abeck D
    MMW Fortschr Med; 2003 Dec; 145(51-52):29. PubMed ID: 14974325
    [No Abstract]   [Full Text] [Related]  

  • 18. Clindoxyl gel for the treatment of acne vulgaris.
    Tan JK
    Skin Therapy Lett; 2002 May; 7(5):1-2. PubMed ID: 12223978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A multicentre, single-blind, randomized comparison of a fixed clindamycin phosphate/tretinoin gel formulation (Velac) applied once daily and a clindamycin lotion formulation (Dalacin T) applied twice daily in the topical treatment of acne vulgaris.
    Zouboulis CC; Derumeaux L; Decroix J; Maciejewska-Udziela B; Cambazard F; Stuhlert A
    Br J Dermatol; 2000 Sep; 143(3):498-505. PubMed ID: 10971320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory effects of tretinoin in combination with clindamycin.
    Wauben-Penris PJ; Cerneus DP; van den Hoven WE; Leuven PJ; den Brok JH; Hall DW
    J Eur Acad Dermatol Venereol; 1998 Sep; 11 Suppl 1():S2-7; discussion S28-9. PubMed ID: 9891902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.